SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001567619-20-018693
Filing Date
2020-11-04
Accepted
2020-11-04 16:33:40
Documents
2
Period of Report
2020-11-02

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 1699
2 poa_curran.htm EX-24 8002
  Complete submission text file 0001567619-20-018693.txt   11198
Mailing Address C/O MYOVANT SCIENCES INC. 320 WEST 37TH STREET, 5TH FLOOR NEW YORK NY 10018
Business Address
Curran Terrie (Reporting) CIK: 0001690298 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39186 | Film No.: 201287178

Mailing Address 2945 TOWNSGATE ROAD SUITE 110 WESTLAKE VILLAGE CA 91361
Business Address 2945 TOWNSGATE ROAD SUITE 110 WESTLAKE VILLAGE CA 91361 805-418-5006
Arcutis Biotherapeutics, Inc. (Issuer) CIK: 0001787306 (see all company filings)

IRS No.: 812974255 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations